Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids
November 15th, 2019
6.4K views
This protocol describes how to mimic suckling-to-weaning transition in vitro using mouse late fetal intestinal organoids cultured for 30 days.
Overview
This protocol describes how to mimic the suckling-to-weaning transition in vitro using mouse late fetal intestinal organoids cultured for 30 days. This model allows for the study of molecular mechanisms involved in gut maturation.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Cell Culture Techniques
Background
- Intestinal maturation is crucial during the suckling-to-weaning transition.
- Using fetal intestinal cells can reduce the need for experimental animals.
- Primary intestinal cells from late developmental stages are essential for this model.
- The protocol outlines the dissection and culture of intestinal organoids.
Purpose of Study
- To develop an in vitro model for studying gut maturation.
- To analyze the effects of external factors on intestinal development.
- To provide insights into the molecular mechanisms of maturation.
Methods Used
- Dissection of intestines from late fetal mice.
- Culture of intestinal crypts in extracellular matrix gel.
- RNA and protein isolation for analysis.
- Assessment of enzyme activity and gene expression over time.
Main Results
- Fetal organoids matured to an adult state after 30 days.
- Distinct expression of proximal and distal markers was observed.
- Extrinsic factors like dexamethasone influenced maturation.
- Gene expression of adult markers increased while fetal markers decreased.
Conclusions
- Late fetal stage organoids are capable of transitioning to adult organoids in vitro.
- This model can help identify modulators of intestinal maturation.
- It offers a valuable alternative to traditional animal studies.
Frequently Asked Questions
What is the significance of using late fetal intestinal cells?
Late fetal intestinal cells are crucial for achieving proper maturation in vitro, mimicking the natural developmental process.
How does this protocol reduce the use of experimental animals?
By using an in vitro model, researchers can study gut maturation without relying solely on live animal experiments.
What external factors were tested in this study?
Dexamethasone was used as an example of an external factor that can accelerate intestinal maturation.
How long does the culture process take?
The culture process lasts for approximately 30 days to achieve maturation.
What are the main markers analyzed in this study?
Proximal markers like Onecut2 and Gata4, and distal markers such as Fabp6 and Guca2a were analyzed.
What is the potential application of this model?
This model can be used to study the effects of various modulators on intestinal maturation and development.
Executive Industry Relevance
Modeling the suckling-to-weaning transition in vitro addresses a key challenge in gastrointestinal development research by providing a reproducible system to study epithelial maturation. This approach supports target validation and mechanistic de-risking for therapies aimed at gut disorders, offering predictive value through quantifiable marker shifts. By reducing reliance on in vivo models, it enables higher-throughput screening of modulators while maintaining physiological relevance.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of genetic programs driving intestinal epithelial maturation, supporting target hypothesis testing.
- Operational Value: Provides a defined system to assess fetal-to-adult marker transitions, facilitating functional validation of novel targets.
- Predictive Value: Tracks expression shifts in lactase, sucrase-isomaltase, and lysozyme over time, allowing early assessment of compound effects on maturation pathways.
Screening & Assay Development
- Scientific Value: Generates quantitative readouts via enzyme activity assays (e.g., sucrase, trehalase) to measure functional maturation.
- Operational Value: Standardizes organoid culture and sampling at fixed intervals post-passage, ensuring reproducible baseline measurements.
- Scalability: Uses 48-well plate format compatible with liquid handling systems for medium-throughput compound testing.
Translational & Preclinical Research
- Translational Continuity: Models a conserved developmental process across mammals, supporting extrapolation of modulator effects to neonatal gut maturation.
- Biomarker Alignment: Links molecular changes (e.g., Blimp-1 downregulation, sucrase-isomaltase upregulation) to functional outcomes like carbohydrate digestion capacity.
- Preclinical De-risking: Allows testing of extrinsic factors (e.g., dexamethasone) to identify accelerators or inhibitors of maturation before in vivo studies.
Pipeline & Workflow Integration
The model fits within early discovery workflows, where mechanistic insights into gut maturation can inform target selection and lead optimization for gastrointestinal disorders.
- Discovery Biology: Supports pathway clarification by linking extrinsic factor exposure to temporal shifts in fetal and adult gene expression profiles.
- Screening: Enables assay-ready organoids with quantifiable enzymatic outputs suitable for compound library screening.
- Analytics: Provides time-resolved RNA and protein isolation workflows to correlate molecular markers with functional enzyme activity.
- Translational Research: Connects in vitro maturation stages to in vivo suckling-to-weaning phenotypes via conserved marker panels.
- Enterprise Reuse: Establishes a scalable platform for repeated testing of nutritional, hormonal, or pharmacological modulators of intestinal development.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in gut maturation by isolating cell-intrinsic programs from systemic variables.
- Operational Value: Defines clear passage and sampling schedules (e.g., RNA isolation every three days post-passage) to ensure longitudinal consistency.
- Strategic Value: Improves go/no-go decisions by enabling early detection of maturation delays or accelerators in response to candidate compounds.
- Portfolio Impact: Supports risk-adjusted prioritization of modulators based on their effect size on adult marker expression kinetics.
Implementation Considerations
- Requires expertise in primary tissue isolation and organoid culture techniques from embryonic day 18–20 mouse fetuses.
- Dependent on extracellular matrix gel handling and sterile dissection protocols to maintain crypt viability.
- Necessitates standardized RNA lysis and enzyme assay buffers for longitudinal molecular and functional analysis.
- Limited to late fetal intestinal cells; earlier stages fail to transition to adult organoids in vitro.
- Assay sensitivity depends on proper substrate preparation (e.g., lactose, sucrose) and PGO color solution freshness for accurate glucose detection.
Biopharma FAQs
Why is RNA isolation performed three days after each passage?
RNA isolation at this fixed interval ensures consistent sampling timing relative to organoid passaging, enabling reliable longitudinal tracking of gene expression changes in fetal and adult markers across culture weeks.
How does dexamethasone treatment affect sucrase-isomaltase activity in the organoid model?
Dexamethasone treatment increases both gene expression and enzyme activity of sucrase-isomaltase compared to controls, indicating accelerated functional maturation toward an adult intestinal phenotype.
What quantitative measurements enable assessment of carbohydrate digestion capacity?
Enzyme activity assays measuring glucose release from substrates like lactose, sucrose, maltose, and trehalose provide quantitative readouts of disaccharidase function, reflecting intestinal maturation status.
Why are replication requirements important for comparing modulator effects?
Replication across wells and litters ensures that observed changes in marker expression or enzyme activity are robust and not due to technical variability, supporting confident cross-functional interpretation of modulator impact.
What statistical analysis is needed before concluding modulator effects on maturation?
Comparative statistical analysis of gene expression and enzyme activity between treated and control organoids over time is required to determine significant differences in maturation kinetics, avoiding false-positive conclusions from single-well observations.
